Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Alligator Bioscience Appoints Sumeet Ambarkhane MD as Chief Medical Officer

Lund, Sweden, February 1, 2022 – Alligator Bioscience (Nasdaq Stockholm: ATORX) Alligator Bioscience (Nasdaq Stockholm: ATORX), today announces the appointment of Sumeet Ambarkhane, MD, as its Chief Medical Officer. In this role, Sumeet will provide medical leadership and direction in the development of Alligator’s best-in-class preclinical and clinical pipeline, including Alligator’s lead assets mitazalimab, a CD40 agonist currently in Phase II clinical development, and ATOR-1017, a 4-1BB agonist in Phase I.    Sumeet is a seasoned professional with over 20 years of drug development

AcadeMedia’s interim report July – December 2021

Second quarter (October – December 2021) · Net sales increased by 9.8 percent and amounted to SEK 3,774 million (3,436). Organic growth, including bolt-on acquisitions, was 6.0 percent. · Operating profit (EBIT) amounted to SEK 342 million (273). · Adjusted operating profit, adjusted for items affecting comparability and effects of IFRS 16, amounted to SEK 263 million (224). Items affecting comparability amounted to SEK 7 million (-9) and include insurance compensation received in relating to a fire in a compulsory school in the first quarter and VAT-expenses relating to the

Össur hf: Interim Report Q4 & FY 2021

Announcement no. 03/2022 Interim report Q4 & FY 2021 1 February 2022 Jon Sigurdsson, President & CEO, comments: “The results for the fourth quarter were solid with especially strong growth in EMEA and APAC. Prosthetics growth was strong in all regions, including Bionics, which has been more affected in prior quarters. This reconfirms our belief that the demand for our advanced and innovative technological solutions remains as we continue to create a Life Without Limitations® for our end-users. We have taken on challenges presented by the COVID-19 pandemic throughout the year and

Implantica Taps Former Medtronic Executive Paul Mead for COO Role

Implantica AG (publ), an emerging and fast growing med-tech company that is pioneering innovative solutions to treat chronic health conditions, announces the appointment of Paul Mead as Chief Operating Officer. Paul brings nearly 20 years of diverse experience at Medtronic to Implantica, having most recently led several Operating Units as Vice President Europe, with additional responsibility spanning EMEA, LATAM and Canada. This appointment further strengthens Implantica’s senior leadership team which is well-balanced and draws from industry leaders.At Medtronic, Paul held positions of

Bonava sells 53 rental apartments in Helsinki

Bonava is selling 53 rental apartments in Helsinki, Finland, to the investor Sirius Capital Partners. The transaction amounts to EUR 16 million and the first housing units are expected to be completed and handed over to the customer in the second quarter of 2023.– We started the collaboration with Sirius Capital Partners in 2021 when they entered the residential sector. We are now very pleased to conclude our second contract with them, says Riku Patokoski, Business Unit President, Bonava Finland. The neighbourhood in question is located in Vuosaari, east Helsinki, a short walk from the

GomSpace (provider of nanosatellites) announces its quarterly results for the fourth quarter 2021

Stockholm, February 1, 2022. GomSpace Group AB (the “Company”) announces its interim report for the fourth quarter of 2021. The report is available on the Company’s homepage (www.gomspace.com). The following is taken from the quarterly report: Fourth quarter summary 1 October – 31 December 2021 (2020) · Order intake increased to T.SEK 286,667 (73,441) · Net revenues increased to T.SEK 81,125 (72,256) · Gross margin increased to 38% (33%) · Operating profit (EBIT) increased to T.SEK 3,473 (310)  · Earnings per share were SEK 0.10 (a negative 0.08) 1 January – 31

Inzile’s Principal Shareholder comments on recent leadership changes

eFashion Championship PTE Ltd (“eFC”) is proposed to join Inzile’s Board of Directors, as a proprietary member, at the Extraordinary General shareholders’ Meeting on February 18, 2022. Enrique Bañuelos, Juan Carlos del Rio and Gloria Bañuelos are proposed by eFC to become part of Inzile’s Board of Directors. This shows the full support and commitment of the eFC Group to develop the company towards a global player in electric mobility solutions.  Board Member Måns Sjöstedt is appointed CEO of Inzile, as it is important for Inzile to have a strong local CEO in Sweden. The former CEO

Finnish startup Jobilla raises €8.25M to build a candidate-driven recruiting funnel that competes in a league of its own

With funding from Juuri Partners and Trind VC, Jobilla can offer its AI-powered recruiting platform to more companies battling with the Great Resignation and War for Talent.Finnish talent acquisition startup Jobilla  has announced the successful closure of an €8.25M funding round led by venture capital investors Juuri Partners  and Trind VC . Jobilla has disrupted recruiting across five different continents by building a recruitment solution where each step of the candidate’s experience is analyzed and optimized to

Oncorena Initiates the Phase I-II Clinical Trial with Orellanine in Advanced Kidney Cancer Patients at Karolinska University Hospital in Sweden

LUND, SWEDEN, February 1, 2022 – Oncorena today announced the initiation of the Phase I-II clinical trial of the first-in-class compound orellanine in patients with advanced kidney cancer on dialysis. The company is dedicated to developing a unique and potential breakthrough therapy for advanced kidney cancer.The drug candidate orellanine, which has an unique mode of action, is being developed for organ-specific chemotherapy with curative potential for patients with advanced kidney cancer undergoing dialysis due to kidney failure. Preclinical evidence shows that orellanine specifically

Sabis chooses Sickla for its new food store

Atrium Ljungberg has signed a lease contract for more than 1,700 m[2] with Sabis, which is going to be expanding and will open a new food store inside the shopping centre Sickla Galleria. The store is part of Sabis’ partnership with Axfood and is going to be called ‘Hemköp Sickla’.Sabis is a family company based in Stockholm that was founded in 1874. It now has 20 restaurants, ten cafes, three hotels and five food stores, including Sabis Fältöversten and four Hemköpsbutiker stores. Its new store in Sickla will be at the western entrance to the shopping centre, next to Curanten, the new

Salmon Evolution ASA: Invitation to presentation of fourth quarter 2021 results

Salmon Evolution will present its fourth quarter 2021 results, followed by a Q&A session, on Thursday, February 10, 2022 at 8:00 a.m. CET. The webcast and subsequent Q&A will be held in English by CEO, Håkon André Berg and CFO, Trond Håkon Schaug-Pettersen. The presentation can be accessed at www.salmonevolution.no, or with the following link: https://streams.eventcdn.net/salmonevolution/2021q4/

Skanska divests the office properties West Memorial I and II in Houston, USA, for USD 147M, about SEK 1.3 billion

Skanska divests the office properties at West Memorial Place I and II in Houston, Texas, USA, for approximately USD 147M, about SEK 1.3 billion, to a joint venture spearheaded by Fuller Realty Interests, LLC. The transaction will be recorded by Skanska USA Commercial Development in the first quarter 2022.West Memorial Place is a 713,000-square feet two building, LEED Platinum office campus located in Houston’s Energy Corridor. West Memorial Place I consists of 331,000 square feet of office space and West Memorial Place II is comprised of 382,000 square feet of office. An early adopter of

Full year and fourth quarter 2021 report

Stockholm – Tele2 AB (“Tele2”) (Nasdaq Stockholm: TEL2 A and TEL2 B) today announces its consolidated results for the full year and fourth quarter 2021.CEO Comment- 2021 was a good year for Tele2 in several ways. As business progressed over the year, we were able to lift our guidance and we are now pleased to announce that we have delivered on these increased targets and that we have created a business that enables us to reiterate our mid-term targets. Further, the Board of Directors has proposed an ordinary dividend of SEK 6.75 per share, a 12.5% increase from last year. We are

Targovax and Prof. Michael Uhlin at Karolinska Institutet enter research collaboration

Targovax has entered into a research collaboration with Prof. Michael Uhlin at Karolinska Institutet to develop and characterize novel ONCOS delivery vectorsOslo, Norway, 1 February 2022 – Targovax ASA (OSE: TRVX), a clinical-stage immuno-oncology company developing immune activators to target hard-to-treat solid tumors, today announces that it has entered into a two-year research collaboration with Prof. Michael Uhlin of the Department of Clinical Science, Intervention and Technology at Karolinska Institutet in Stockholm, Sweden, to develop and characterize novel ONCOS oncolytic viruses.

Josemaria Share Capital and Voting Rights Update

VANCOUVER, BC, January 31, 2022 /CNW/ - Josemaria Resources Inc. (TSX: JOSE) (OMX: JOSE) (OTCQB: JOSMF) ("Josemaria Resources" or the "Company") reports that, in accordance with the Swedish Financial Instruments Trading Act, as a result of the issuance of common shares pursuant to the terms of previously announced credit facilities during the month of January, 2022, the number of issued and outstanding shares of the Company has increased to 381,835,940 common shares with voting rights as at January 31, 2022.   Additional Information This is information that the Company is obliged

Lundin Gold Share Capital and Voting Rights Update

VANCOUVER, BC, Jan. 31, 2022 /CNW/ - Lundin Gold Inc. (TSX: LUG; Nasdaq Stockholm: LUG) ("Lundin Gold" or the "Company") reports the following in accordance with the Swedish Financial Instruments Trading Act.   As a result of the exercise of stock options issued under Lundin Gold’s Omnibus Equity Incentive Plan during the month of January, the Company now has 233,373,983 common shares issued and outstanding with voting rights as at January 31, 2022.    This figure may be used by shareholders as the denominator for the calculation by which they will determine if they are required

Lundin Mining Announces Updated Share Capital and Voting Rights

Toronto, January 31, 2022 /CNW/ - (TSX: LUN; Nasdaq Stockholm: LUMI) Lundin Mining Corporation (“Lundin Mining” or the “Company”) reports the following updated share capital and voting rights, in accordance with the Swedish Financial Instruments Trading Act: The number of issued and outstanding shares of the Company has increased by 768,800 to 735,755,954 common shares with voting rights as at January 31, 2022. The increase in the number of issued and outstanding shares from January 1, 2022 to date is a result of the exercise of employee stock options or the vesting of employee share

Enersense’s Board decided on a directed share issue of 2,598,331 new Enersense shares in relation to the Megatuuli transaction - the transaction is estimated to be completed on 1 February 2022

Enersense International Plc Stock Exchange Release, 31 January 2022 at 11:50 p.m.NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION. FOR FURTHER INFORMATION, PLEASE SEE THE “IMPORTANT NOTICE” BELOW.  Enersense International Plc (“Enersense”), a provider of zero-emission energy solutions,

Måns Sjöstedt takes over as CEO of Inzile

Board Member Måns Sjöstedt takes over as CEO of Inzile with immediate effect. Måns Sjöstedt has been Inzile’s Acting General Manager for the Nordic region. Måns Sjöstedt has extensive experience from international business after many years as CEO in global organizations and as CEO of a Swedish public company.   - We are very pleased that Måns Sjöstedt takes over the CEO position and we believe that, in this phase of Inzile’s development, it is an advantage that he is based in Stockholm, comments Håkan Örtenholm, Chairman of the Board of Inzile. Måns Sjöstedt will continue to focus his

Nordea Bank Abp: Repurchase of own shares on 31.01.2022

Nordea Bank AbpStock exchange release – Changes in company’s own shares31.01.2022 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 31.01.2022 completed repurchases of own shares (ISIN: FI4000297767) as follows: Trading Number of Weighted average Total cost, EUR* **venue (MIC shares price / share, EUR* Code) **XSTO 378,281 10.57 3,998,028.55XHEL 253,498 10.55 2,674,378.55CEUX 327,980 10.56 3,463,746.50AQEU 26,004 10.56

Notice of Extraordinary General Meeting of Inzile AB (publ)

The shareholders of Inzile AB (publ), 556907-0070, (the "Company") are hereby given notice to attend the Extraordinary General Meeting on Friday 18 February 2022 at 14:00 CET at WeWork Urban Escape, Malmskillnadsgatan 32, 111 51 Stockholm. The board of directors has decided, pursuant to Chapter 7, section 4 a of the Swedish Companies Act and the company’s articles of association, that shareholders shall have the right to exercise their voting rights by postal voting prior to the general meeting. Consequently, shareholders may choose to exercise their voting rights at the general meeting

BEWI - Result of tender offer to acquire remaining shares in IZOBLOK

Reference is made to the stock exchange release dated 2 November 2021 about BEWI ASA`s tender offer to acquire remaining shares in the listed Polish company IZOBLOK Spólka Akcyjna (“IZOBLOK”), a leading European provider of Expanded Polypropylen (EPP) components to the automotive industry. Under the tender offer, BEWI has received acceptances for a total of 121 870 shares at a price per share of PLN 50.41, amounting to a total consideration of approximately EUR 1 350 000. Settlement of the transaction is expected on or about 7 February 2022. BEWI ASA will after this transaction (

Conversion of shares

According to Husqvarna AB´s articles of association, owners of Class A shares have the right to have such shares converted to Class B shares. Conversion reduces the total number of votes in Husqvarna AB. When such a conversion has occurred, the company is obligated by the Act on Trading in Financial Instruments to disclose any such change. In December 2021, at the request of shareholders, 204,207 Class A shares were converted to Class B shares. The total number of votes thereafter amounts to 157,430,682.5. The total number of registered shares in the company amounts to 576,343,778

Change of number of shares and votes in Green Landscaping Group AB (publ)

31 January 2022, 18:30 CET Pursuant to the Swedish Financial Instruments Trading Act (Sw. lagen (1991:980) om handel med finansiella instrument), Swedish companies whose shares are listed on a regulated market and who increases or reduces the total number of shares or votes in the company is to disclose such changes on the last trading day the same month.As of 31 January 2022, there is in total 53 142 631 shares and votes in Green Landscaping Group AB (publ) (“Green” or the “Company”). The change in number of shares and votes in the Company is a result of the board of directors’

There are no items matching the current filter
There are no more items matching the current filter
Back to top